Exchange: NASDAQ·Updated 06:28 PM EST
MPLT logo

MPLT MapLight Therapeutics Inc.

$5.93
$0.48
(7.48%)
Today
Closed $5.94
$0.01
(0.17%)
After Hours
Reported EarningsNov 16
Mkt Cap$356.8M
Vol357,939.00

About MPLT

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.
55

Bullish Sentiment

How do you feel about MPLT?

Advertisement|Remove ads.